We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Swab-Based Rapid Test Uses UV Spectrometer to Detect All COVID-19 Variants

By LabMedica International staff writers
Posted on 08 Apr 2022
Print article
Image: Faster, cheaper COVID tests could improve diagnostic testing (Photo courtesy of Unsplash)
Image: Faster, cheaper COVID tests could improve diagnostic testing (Photo courtesy of Unsplash)

A new swab-based rapid test uses a UV spectrometer for detection of the spike protein of SARS-CoV-2 and will cover all COVID-19 variants, as well as any future variants.

In August 2020, a nanotechnology research group at the University of Georgia (Athens, GA, USA) had tested nanotechnology-based optical sensors designed for COVID-19 detection and saw the potential for their home-grown technology. The group has now filed a patent application and published its first paper on rapid detection of COVID-19, using a localized surface plasmon resonance (LSPR) virus sensor, developed based on human angiotensin-converting enzyme 2 protein (ACE2) functionalized silver nanotriangle arrays. The sensor has high sensitivity and specificity to the spike protein RBD of SARS-CoV-2 as well as human coronavirus NL63. The team is now developing a detector based on this work within USD 10 and the sensor will link to a smartphone app.

“Right now, we already have rapid antigen test kits available on the market, though the big issue continues to be the high rate of false positives, around 60%,” said Yanjun Yang, doctoral student in the UGA College of Engineering and lead author on the new paper. “Our technology, also in a rapid kit but using a spectrometer to do the detection, is much more accurate.”

“The method we developed shall have a much better sensing performance than the rapid test kits, very close to the PCR tests currently in use,” said Yiping Zhao, Distinguished Research Professor in the Franklin College of Arts and Sciences department of physics and astronomy. “The setup and the operation of the sensor is very simple, and the test time essentially will be less than 10 minutes.”

“The LSPR sensor has several advantages in rapid diagnostics of SARS-CoV-2 (CoV2). Highly sensitive, specific, and able to detect CoV2 at picomolar concentrations in saliva, it’s rapidity at less than 20 minutes is as good or better than current diagnostic platforms including RT-qPCR, also known as the ‘gold standard’,” said Ralph Tripp, professor and GRA Chair in Vaccine and Therapeutic Development in the College of Veterinary Medicine department of infectious diseases and co-author on the study. “In addition, this method of detection is highly reproducible. This platform is a significant leap forward in diagnostics.”

Related Links:
University of Georgia 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more